As we head into what is anticipated to be a strong year for biopharma dealmaking, we look back at some of the biggest deals in 2025 that focus on biologics and biosimilars.
Antibody Therapy Deals
Novartis acquires Avidity Biosciences
On October 26, 2025, Novartis AG and Avidity Biosciences, Inc. announced that they had entered into
USPTO Issues Guidance on Subject Matter Eligibility Declarations (“SMED”)
On December 4, 2025, the United States Patent and Trademark Office (USPTO) issued two memoranda addressing the use of Subject Matter Eligibility Declarations (“SMEDs”) during patent prosecution, both from Director John Squires. The first, the SMED Examiner Memo, targets the Patent Examining Corps, clarifying how examiners should treat applicant-submitted evidence under 37 CFR 1.132
Recap of the Top Read Blog Posts in 2025
Happy New Year! 2025 was a busy year for the Insider authors—we published 271 posts throughout 2025. To kick-off 2026, in case you missed them last year, we are providing the articles from 2025 that were the most interesting to our readers across various categories.
We hope you enjoy them and look forward to another
The Briefing: New York Times v. Perplexity AI: Copyright, Hallucinations, and Trademark Risk
In this episode of The Briefing, Weintraub Tobin partners Scott Hervey and Matt Sugarman break down The New York Times v. Perplexity AI, a lawsuit that goes beyond copyright and into largely untested trademark territory. They discuss the Times’ allegations that Perplexity copied its journalism at both the input and output stages and, more
Lights, Camera, [AI] Action: India’s Recent Celebrity Deepfake Lawsuits
December 2025 saw India’s courts in New Delhi and Mumbai tackle a new breed of lawsuits: leading Indian cinema celebrities fighting back against unauthorized deepfakes and AI-generated impersonations. Nandamuri Taraka Rama Rao (NTR Jr.), R. Madhavan, and Shilpa Shetty—all famous Indian actors—filed and won powerful court orders aimed at blocking the spread of synthetic images,
The Human Edge: Why Upskilling Legal Teams is the Heart of GenAI Adoption
While the disruptive potential of generative AI in legal services dominates headlines, the real story lies with the individuals making that transformation possible. For in-house legal teams and law firms facing rapid shifts in regulation and technology, upskilling has evolved from a competitive advantage into the foundation of any successful AI strategy.
Technology Isn’t the
Lawsuit Alleges Fireflies.AI Corp. Illegally Collects Biometric Data from Virtual Meetings
A new lawsuit filed in Illinois federal court is shining a spotlight on the legal risks tied to AI-powered meeting assistants that offer transcription and speaker identification services on platforms like Zoom and Microsoft Teams. The complaint, brought by Illinois resident Katelin Cruz, alleges that California-based tech company Fireflies.AI Corp. is illegally harvesting and storing
State AG’s Oppose FCC’s Efforts to Preempt State Laws Regulating AI
On December 17, 2025, a bipartisan group of 23 Attorneys General from the states of Arizona, California, Colorado, Connecticut, Delaware, Hawai’i, Illinois, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Rhode Island, Tennessee, Utah, Vermont, Washington, Wisconsin, and the District of Columbia, sent a comment letter to the Federal Communications Commission
Keeping Hong Kong’s registered design system up to date with the modern world
In our previous blog posts here and here, we reported on the Hong Kong government’s efforts to update the Copyright Ordinance to align with the latest technological developments, especially in relation to artificial intelligence. This month, the government released a further public consultation to update the Registered Designs Ordinance (RDO) in view of global
La Divisione Locale di Milano dell’UPC chiarisce i requisiti per la concessione di misure di preservation of evidence
Con due recenti provvedimenti, la Divisione Locale di Milano del Tribunale Unificato dei Brevetti (UPC), già distintasi nel panorama europeo per l’approccio pragmatico in tema di provvedimenti cautelari, ha chiarito alcuni importanti profili in tema di concessione delle misure cautelari di raccolta della prova previste nel sistema UPC (equivalenti alla descrizione italiana o alle saisie